Aptevo Therapeutics Inc.

APVO · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$8,714$16,904$22,635$45,044
Short-Term Investments$0$0$0$0
Receivables$0$0$2,500$3,664
Inventory$0$0$0$0
Other Curr. Assets$1,945$2,162$2,315$3,862
Total Curr. Assets$10,659$19,066$27,450$52,570
Property Plant & Equip (Net)$4,932$5,776$6,765$3,963
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$0$68
Total NC Assets$4,932$5,776$6,765$4,031
Other Assets$0$0$0$0
Total Assets$15,591$24,842$34,215$56,601
Liabilities
Payables$3,053$0$0$0
Short-Term Debt$0$0$2,000$11,667
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$3,154$7,224$6,706$23,090
Total Curr. Liab.$6,207$7,224$8,706$34,757
LT Debt$4,629$5,397$7,535$5,048
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$15,580
Total NC Liab.$4,629$5,397$7,535$20,628
Other Liabilities$0$0$0$0
Cap. Leases$4,629$5,397$6,079$1,341
Total Liabilities$10,836$12,621$16,241$55,385
Equity
Pref Stock$0$0$0$0
Common Stock$84$61$48$47
Retained Earnings-$247,577-$223,447-$206,036-$214,063
AOCI$0$0$0$0
Other Equity$252,248$235,607$223,962$215,232
Total Equity$4,755$12,221$17,974$1,216
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$15,591$24,842$34,215$56,601
Net Debt-$4,085-$11,507-$13,100-$28,329